Conventional drug therapies suffer from several limitations most prominently the pharmacokinetic alterations in biological system which results in decreased bioavailability at the desired site of action. Furthermore, the undesired distribution, biotransformation and elimination lead to cause serious toxicities and sub-maximal therapeutic efficacy. The concept of Targeted Drug Delivery Systems (TDDS) thus emerged to limit these consequences and exaggerate the therapeutic value of the medicine.

Dr. Dipanjana Ghosh obtained her PhD degree from National University of Singapore in 2013. She has worked as Post-doctoral Research Fellow in NUS and Associate Professor in School of Pharmacy & Research, People's University, Bhopal. She has diversified expertise in the field of Pharmaceutical and Life Sciences.